Drug development in higher-risk myelodysplastic syndromes
Blood Cancer J
.
2024 Oct 24;14(1):187.
doi: 10.1038/s41408-024-01171-y.
Authors
Sangeetha Venugopal
1
,
Mikkael A Sekeres
2
Affiliations
1
Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA. svenugopal@miami.edu.
2
Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, USA.
PMID:
39448568
PMCID:
PMC11502867
DOI:
10.1038/s41408-024-01171-y
No abstract available
Publication types
Letter